Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer

Clinical trial NCT01120236 · COMPLETED

Trial details

NCT number: NCT01120236
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Adenocarcinoma Recurrent Prostate Carcinoma Stage IV Prostate Cancer

Start date: 2010-12-01
Primary completion: 2015-06-01
Enrollment: 211

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.